ScienceDaily (Oct. 22, 2008) — Melanoma patients infused with a special type of tumor-fighting T cell are more likely to survive without relapse, suggests a new study by researchers in France.
ScienceDaily (Oct. 22, 2008) — Melanoma patients infused with a special type of tumor-fighting T cell are more likely to survive without relapse, suggests a new study by researchers in France.
